glp-1 and inflammation Anti-inflammatory properties of receptor agonists other ancillary benefits from a pharmacological perspective GLP-1 RAs may lead to
Description
J Am Coll Cardiol 2024;84:1587-602.ArticlePubMed 97
Cukierman-Yaffe T, Gerstein HC, Colhoun HM, Diaz R, Garca-Prez LE, Lakshmanan M, et al
95% CI 1.53 to 18.63
The mechanistic evidence is promising, but human trials are still needed, and endometriosis presents complexity as a full-body disease
Adipose tissue inflammation and metabolic dysfunction in obesity
